40 related articles for article (PubMed ID: 7527295)
1. Study of Serum Total PSA and Free PSA as an Oncological Marker in Breast Tumour.
Jahir ET; Devi R; Borthakur BB
J Clin Diagn Res; 2017 Mar; 11(3):BC13-BC16. PubMed ID: 28511371
[TBL] [Abstract][Full Text] [Related]
2. Does Rigid Cystoscopy Affect the Total Serum Prostate-Specific Antigen Levels?
Singh I; Prasad R; Agarwal V; Tripathi RL
Indian J Surg; 2015 Dec; 77(Suppl 2):365-9. PubMed ID: 26730027
[TBL] [Abstract][Full Text] [Related]
3. Reconnoitring the status of prostate specific antigen and its role in women.
Dash P
Indian J Clin Biochem; 2015 Apr; 30(2):124-33. PubMed ID: 25883418
[TBL] [Abstract][Full Text] [Related]
4. Positive resection margins may not reflect the true margin in patients undergoing radical prostatectomy.
Furubayashi N; Negishi T; Hirata Y; Taguchi K; Shimokawa M; Nakamura M
Oncol Lett; 2014 Nov; 8(5):2237-2242. PubMed ID: 25295112
[TBL] [Abstract][Full Text] [Related]
5. Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies.
Schmitt M; Magdolen V; Yang F; Kiechle M; Bayani J; Yousef GM; Scorilas A; Diamandis EP; Dorn J
Radiol Oncol; 2013; 47(4):319-29. PubMed ID: 24294176
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients.
Ylikoski A; Karp M; Pettersson K; Lilja H; Lövgren T
J Mol Diagn; 2001 Aug; 3(3):111-22. PubMed ID: 11486050
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen (PSA/hK3): a further player in the field of breast cancer diagnostics?
Mannello F; Gazzanelli G
Breast Cancer Res; 2001; 3(4):238-43. PubMed ID: 11434875
[TBL] [Abstract][Full Text] [Related]
8. Prostate Cancer - Old Problems and New Approaches. (Part II. Diagnostic and Prognostic Markers, Pathology and Biological Aspects).
Honn KV; Aref A; Chen YQ; Cher ML; Crissman JD; Forman JD; Gao X; Grignon D; Hussain M; Porter AT; Pontes EJ; Powell I; Redman B; Sakr W; Severson R; Tang DG; Wood DP
Pathol Oncol Res; 1996; 2(3):191-211. PubMed ID: 11173606
[TBL] [Abstract][Full Text] [Related]
9. Molecular chemotherapy for breast cancer.
Patterson A; Harris AL
Drugs Aging; 1999 Feb; 14(2):75-90. PubMed ID: 10084362
[TBL] [Abstract][Full Text] [Related]
10. Equivalent recognition of free and ACT-complexed PSA in a monoclonal-polyclonal sandwich assay is conferred by binding specificity of the monoclonal antibody.
Zhou Z; Armstrong EG; Belenky A; Freeman JV; Yeung KK
J Clin Lab Anal; 1998; 12(4):242-9. PubMed ID: 9671177
[TBL] [Abstract][Full Text] [Related]
11. Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue.
Yu H; Diamandis EP; Levesque M; Giai M; Roagna R; Ponzone R; Sismondi P; Monne M; Croce CM
Breast Cancer Res Treat; 1996; 40(2):171-8. PubMed ID: 8879683
[TBL] [Abstract][Full Text] [Related]
12. Reverse transcriptase-polymerase chain reaction for prostate-specific antigen may be a prognostic indicator in breast cancer.
Lehrer S; Terk M; Piccoli SP; Song HK; Lavagnini P; Luderer AA
Br J Cancer; 1996 Sep; 74(6):871-3. PubMed ID: 8826851
[TBL] [Abstract][Full Text] [Related]
13. Prostate specific antigen--a new constituent of breast cyst fluid.
Diamandis EP; Yu H; López-Otín C
Breast Cancer Res Treat; 1996; 38(3):259-64. PubMed ID: 8739078
[TBL] [Abstract][Full Text] [Related]
14. Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids.
Mannello F; Bocchiotti G; Bianchi G; Marcheggiani F; Gazzanelli G
Breast Cancer Res Treat; 1996; 38(3):247-52. PubMed ID: 8739076
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific antigen in serum of women with breast cancer.
Giai M; Yu H; Roagna R; Ponzone R; Katsaros D; Levesque MA; Diamandis EP
Br J Cancer; 1995 Sep; 72(3):728-31. PubMed ID: 7545417
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of prostate-specific antigen messenger RNA expressed in breast tumors.
Monne M; Croce CM; Yu H; Diamandis EP
Cancer Res; 1994 Dec; 54(24):6344-7. PubMed ID: 7527295
[TBL] [Abstract][Full Text] [Related]
17. Detection of hematogenous micrometastasis in patients with prostate cancer.
Moreno JG; Croce CM; Fischer R; Monne M; Vihko P; Mulholland SG; Gomella LG
Cancer Res; 1992 Nov; 52(21):6110-2. PubMed ID: 1382851
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study.
Yu H; Levesque MA; Clark GM; Diamandis EP
Clin Cancer Res; 1998 Jun; 4(6):1489-97. PubMed ID: 9626467
[TBL] [Abstract][Full Text] [Related]
19. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S
Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
